> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FY 2022 Biosimilar User Fee Rates Set
- URL: https://www.fdaweb.com/fy-2022-biosimilar-user-fee-rates-set/
- Published: 2021-07-27T12:00:00.000Z
- Updated: 2026-09-14T17:07:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149789

*Federal Register* notice: FDA is announcing the rates for biosimilar user fees for fiscal year 2022\. The initial and annual biological product development fee is $57,184\. The fee for an application requiring clinical data is $1,746,745, and the fee for an application not requiring clinical data is $873,373\. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-16084.pdf?ref=fdaweb.com).